Skip to main content
Log in

Multi-faceted Anti-obesity Effects of N-Methyl-D-Aspartate (NMDA) Receptor Modulators: Central-Peripheral Crosstalk

  • Research
  • Published:
Journal of Molecular Neuroscience Aims and scope Submit manuscript

Abstract

Hypothalamus is central to food intake and satiety. Recent data unveiled the expression of N-methyl-D-aspartate receptors (NMDAR) on hypothalamic neurons and their interaction with GABAA and serotoninergic neuronal circuits. However, the precise mechanisms governing energy homeostasis remain elusive. Notably, in females, the consumption of progesterone-containing preparations, such as hormonal replacement therapy and birth control pills, has been associated with hyperphagia and obesity—effects mediated through the hypothalamus. To elucidate this phenomenon, we employed the progesterone-induced obesity model in female Swiss albino mice. Four NMDAR modulators were selected viz. dextromethorphan (Dxt), minocycline, d-aspartate, and cycloserine. Obesity was induced in female mice by progesterone administration for 4 weeks. Mice were allocated into 7 groups, group-1 as vehicle control (arachis oil), group-2 (progesterone + arachis oil), and group-3 as positive-control (progesterone + sibutramine); other groups were treated with test drugs + progesterone. Various parameters were recorded like food intake, thermogenesis, serum lipids, insulin, AST and ALT levels, organ-to-body weight ratio, total body fat, adiposity index, brain serotonin levels, histology of liver, kidney, and sizing of fat cells. Dxt-treated group has shown a significant downturn in body weight (p < 0.05) by a decline in food intake (p < 0.01), organ-to-liver ratio (p < 0.001), adiposity index (p < 0.01), and a rise in body temperature and brain serotonin level (p < 0.001). Dxt demonstrated anti-obesity effects by multiple mechanisms including interaction with hypothalamic GABAA channels and anti-inflammatory and free radical scavenging effects, improving the brain serotonin levels, and increasing insulin release from the pancreatic β-cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10
Fig. 11
Fig. 12
Fig. 13

Similar content being viewed by others

Data Availability

Data are available with the corresponding author and will be provided as needed.

Abbreviations

5-HT:

5-Hydroxytryptamine

AgRP:

Agouti-related protein

Akt:

Protein kinase b (pkb)

ARRIVE:

Animal Research: Reporting of In Vivo Experiments

ALT:

Alanine transaminase

AMPA:

α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid

ARC:

Arcuate nucleus

AST:

Aspartate aminotransferase

BAT:

Brown adipose tissue

BMI:

Body mass index

BMR:

Basal metabolic rate

CART:

Cocaine- and amphetamine-related transcript

Dxt:

Dextromethorphan

EDTA:

Ethylenediaminetetraacetic acid

FoxO1:

Factor forkhead box protein 1

GABA:

Gamma-aminobutyric acid

GABAA :

Gamma-aminobutyric acid channel A

HCl:

Hydrochloric acid

HDL:

High-density lipoprotein

HRT:

Hormone replacement therapy

IR’s:

Insulin receptors

LDL:

Low-density lipoprotein

MC4R:

Melanocortin 4 receptor

NA:

Noradrenaline

NMDA:

The N-methyl-D-aspartate

NMDAR:

The N-methyl-D-aspartate receptor

NYP:

Neuropeptide Y

ObRb:

Leptin receptors

PI3K:

Phosphoinositide 3-kinase

POMC:

Proopiomelanocortin-expressing

PVN:

Paraventricular nucleus

Pyy:

Pancreatic peptide YY

STAT3:

Signal transducer and activator of transcription 3

TC:

Total cholesterol

TG:

Triglycerides

VLDL:

Very-low-density lipoprotein

WAT:

White adipose tissue

WHO:

World Health Organization

α-MSH:

α-Melanocyte stimulating hormone

References

Download references

Acknowledgements

The authors are thankful to the Research and Development department of the Raghavendra Institute of Pharmaceutical Education and Research, Anantapur, India, for providing the necessary facilities for the successful completion of work.

Funding

None.

Author information

Authors and Affiliations

Authors

Contributions

V.R.C., H.C.: Conceptualization; Shabnam Sultana: Methodology, Ethical permission, animal care, and handling; S.S.S., Sudarshan Singh: Data analysis; R.M., Sudarshan Singh: Writing the first draft of the manuscript; HC, Sudarshan Singh: Writing—review and editing; VRC, HC: Supervision. All authors contributed equally and agreed to the submitted version of the manuscript.

Corresponding author

Correspondence to Vijay R. Chidrawar.

Ethics declarations

Ethical Approval

The present study was approved by the Institutional Animals Ethics Committee (Ref: IAEC/I/01/RIPER/2022) Raghavendra Institute of Pharmaceutical Education and Research (RIPER), Anantapur, India. The reported research has strictly followed the national guidelines (CPCSEA) for the research on the experiments animals.

Competing Interests

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shiromwar, S.S., Chidrawar, V.R., Singh, S. et al. Multi-faceted Anti-obesity Effects of N-Methyl-D-Aspartate (NMDA) Receptor Modulators: Central-Peripheral Crosstalk. J Mol Neurosci 74, 13 (2024). https://doi.org/10.1007/s12031-023-02178-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s12031-023-02178-z

Keywords

Navigation